leisure time -WSS

leisure time

author：focus 2025-09-03 12:07:14 - browse：8

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Food as medicine: Medically tailored meals may get standardized

focus

entertainment

WSS

Decaf coffee targeted by food safety group under obscure FDA rule

Who are the detained American citizens released from prison in Iran?

Merck drug for rare lung condition set for approval in U.S.

An innovative path out of biotech’s “valley of death”

Scientists boost immune system in aging mice by making it youthful

Food as medicine: Medically tailored meals may get standardized

focus

leisure time

leisure time

Activists slam private health insurers over coverage restrictions

GOP presidential candidates start declaring their loyalty

After affirmative action ruling, medical educators look to 'holistic review'

Genentech weighs delaying cancer therapy after drug pricing law

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

What does generative AI mean for health care? We asked experts

Readout Newsletter: Merck, Vertex, and Viking updates

How to save PrEP access — and even expand it

Decaf coffee targeted by food safety group under obscure FDA rule

Wikipedia

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Readout Newsletter: Merck, Vertex, and Viking updates

Covid vaccine financial winners and losers, from Pfizer to Novavax

Vertex Pharmaceuticals may move headquarters in Boston

The history of OxyContin, told through Purdue Pharma documents

The history of OxyContin, told through Purdue Pharma documents

focus

focus

entertainment

knowledge